LeMaitre Vascular Inc (LMAT)

91.38 -0.74 (-0.80%) USD  |  NASDAQ  |  Dec 23, 16:00
93.49 +2.11 (+2.31%) Pre-Market: 08:01
More

LeMaitre Vascular Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for LMAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Baxter International Inc Upgrade
Insulet Corp Upgrade
Globus Medical Inc Upgrade
ResMed Inc Upgrade
Perspective Therapeutics Inc --